Frontiers in Immunology

Review

Published on 17 Jan 2024

Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics

in Cancer Immunity and Immunotherapy

Nathaly Poveda-Garavito
Alba Lucía Combita

Frontiers in Immunology

doi 10.3389/fimmu.2023.1325255

3,875 views
1 citation

Review

Published on 17 Jan 2024

HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker

in Cancer Immunity and Immunotherapy

Karim Amrane
Coline Le Meur
Benjamin Besse
Patrice Hemon
Pierre Le Noac’h
Olivier Pradier
Christian Berthou
Ronan Abgral
Arnaud Uguen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1285895

5,792 views
15 citations

Review

Published on 17 Jan 2024

The Na/K-ATPase role as a signal transducer in lung inflammation

in Inflammation

Adriana Ribeiro Silva
Kauê Franscisco Correa de Souza e Souza
Thamires Bandeira De Souza
Mauricio Younes-Ibrahim
Patrícia Burth
Hugo Caire de Castro Faria Neto
Cassiano Felippe Gonçalves-de-Albuquerque

Frontiers in Immunology

doi 10.3389/fimmu.2023.1287512

4,108 views

Original Research

Published on 17 Jan 2024

Prevalence of IgG antibodies against Malawi polyomavirus in patients with autoimmune diseases and lymphoproliferative disorders subjected to bone marrow transplantation

in Viral Immunology

Jérôme T. J. Nicol
Elisa Mazzoni
Maria Rosa Iaquinta
Raffaella De Pace
Pauline Gaboriaud
Natalia Maximova
Carolina Cason
Eleonora De Martino
Chiara Mazziotta
Pierre Coursaget

Frontiers in Immunology

doi 10.3389/fimmu.2023.1293313

1,739 views
2 citations

Original Research

Published on 17 Jan 2024

Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks

in Cancer Immunity and Immunotherapy

Yan Xu
Xiaoyu Sun
Guangxu Liu
Hongze Li
Meng Yu
Yuyan Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1301157

3,360 views
6 citations

General Commentary

Published on 17 Jan 2024

Commentary: Causal associations of gut microbiota and metabolites on sepsis: a two-sample Mendelian randomization study

in Inflammation

Jiamin Xu
Hongyan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1339176

3,294 views

Original Research

Published on 17 Jan 2024

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination

in Vaccines and Molecular Therapeutics

Murat Gainullin
Lorenzo Federico
Julie Røkke Osen
Viktoriia Chaban
Hassen Kared
Amin Alirezaylavasani
Fridtjof Lund-Johansen
Gull Wildendahl
Jon-Aksel Jacobsen
Hina Sarwar Anjum

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235210

3,067 views

Editorial

Published on 17 Jan 2024

Editorial: Immunometabolism and nutritional regulation of intestinal mucosal immunity

in Nutritional Immunology

Yingying Feng
Wai San Cheang
Renyou Gan
Xin Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365690

2,118 views

Original Research

Published on 17 Jan 2024

Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor

in Cancer Immunity and Immunotherapy

Hailang Yang
Li Ma
Wen Deng
Bin Fu
Jianqiang Nie
Xiaoqiang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1301945

3,118 views

Review

Published on 17 Jan 2024

Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer

in Cancer Immunity and Immunotherapy

Merissa Coleman
Sophia J. Mascialino
Anusha Panjwani
Emily Edwards
Vidula V. Sukhatme
Christina Gavegnano
Vikas P. Sukhatme

Frontiers in Immunology

doi 10.3389/fimmu.2023.1281744

5,821 views
1 citation

Original Research

Published on 17 Jan 2024

Macleaya cordata isoquinoline alkaloids attenuate Escherichia coli lipopolysaccharide-induced intestinal epithelium injury in broiler chickens by co-regulating the TLR4/MyD88/NF-κB and Nrf2 signaling pathways

in Comparative Immunology

Yang Liu
Kai Han
Hua Liu
Gang Jia
Luke Comer
Guanlin Wang
Zizhu Pan
Yiqian Zhao
Shuzhen Jiang
Ning Jiao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1335359

2,807 views
6 citations

Review

Published on 17 Jan 2024

A double-edged sword: interactions of CX3CL1/CX3CR1 and gut microbiota in systemic lupus erythematosus

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Rana A. Estaleen
Christopher M. Reilly
Xin M. Luo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1330500

3,235 views
3 citations

Review

Published on 17 Jan 2024

From MASH to HCC: the role of Gas6/TAM receptors

in Inflammation

Daria Apostolo
Luciana L. Ferreira
Federica Vincenzi
Nicole Vercellino
Rosalba Minisini
Federico Latini
Barbara Ferrari
Michela E. Burlone
Mario Pirisi
Mattia Bellan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1332818

8,473 views
9 citations

Original Research

Published on 17 Jan 2024

The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context

in Cancer Immunity and Immunotherapy

Tzu-Yi Chia
Leah K. Billingham
Lauren Boland
Joshua L. Katz
Victor A. Arrieta
Jack Shireman
Aurora-Lopez Rosas
Susan L. DeLay
Kaylee Zillinger
Yuheng Geng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1331287

6,347 views
11 citations

Systematic Review

Published on 17 Jan 2024

Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Xiao Han
Haidong Zhang
Kai Sun
Jing Li
Wanjuan Wu
Kai Liu
Zhenkun Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1302840

2,736 views
2 citations

Editorial

Published on 17 Jan 2024

Editorial: Cellular and systemic interplay of metabolism and inflammation in the pathogenesis of lung diseases

in Inflammation

Adan Chari Jirmo
Melanie Albrecht
Slaven Crnkovic
Miguel Angel Alejandre Alcazar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1352304

1,209 views
1 citation